Akosua Mireku is a healthcare reporter for Pharmaceutical Technology. Akosua has a Bsc in medical physiology from the University of Manchester. She is particularly interested in topics in neuroscience, rare diseases, and global health equality
The FDA has granted Mounjaro, drug that showed comparable potential to gastric bypass surgery, a Fast Track designation to treat obesity.
This week, NICE rejected five major Covid-19 therapies due to high costs and uncertainties in clinical evidence.
A study researching Covid-19 symptoms suggests that Covid-19 rebound may occur regardless of Paxlovid treatment.
Experts suggest that research into diseases that particularly affect people on the continent could be the key to the pharma sector’s growth.
Amidst a swap in UK leadership, the pharmaceutical industry hopes Rishi Sunak will free up funding and boost the economy.
Get industry leading news, data and analysis delivered to your inbox
European countries embrace electronic health records (EHRs) to improve healthcare as funding and innovation accelerate in the field.
New data outlines the potential benefits for the pharmaceutical industry of reducing health disparities to meet its ESG goals.
A new study identifies a novel cerebrospinal fluid biomarker for Parkinson’s disease, expanding the scope of possible drug targets.
A new MHRA approval of melatonin for children with ADHD brings forth questions about the drug’s prescription-only status.
Inflation is at an all-time high, opening an opportunity for CDMOs to invest in potentially cheaper sustainable alternatives.